Skip to main content

Table 1 Patient characteristics

From: Symptom palliation of hypofractionated radiotherapy for patients with incurable inflammatory breast cancer

Characteristic

 

Number of patients

Age (years)

 

Median: 66 (range, 39–90)

ECOG PS

0 or 1

20 (90.9%)

2

2 (9.1%)

Pathology

IDC

20 (90.9%)

IMC

2 (9.1%)

N stage

0 or 1

2 (9.1%)

2 or 3

20 (90.9%)

M stage

0

10 (45.5%)

1

12 (54.5%)

Previous CTx or HTx history

Yes

9 (40.9%)

No

13 (59.1%)

Prescribed dose (BED)

70–80 Gy

7 (31.8%)

≥80 Gy

15 (68.2%)

  1. ECOG Eastern Cooperative Oncology Group, PS performance status, IDC invasive ductal carcinoma, IMC invasive medullary carcinoma, CTx chemotherapy, HTx hormone therapy, BED biologically effective dose